Mounjaro®
Starting from £179.99/mo
Start journey Learn moreWegovy can cause skin itching in some people, but it is not one of the commonly reported reactions. The most frequently reported side effects are gastrointestinal — nausea, constipation, indigestion — and skin itching tends to affect a small minority. That said, there are a few distinct reasons it can happen, and knowing which one applies matters for what you should do next. Wegovy is a prescription-only medicine (semaglutide, by Novo Nordisk) that requires clinical assessment before it can be prescribed; a prescriber reviews your full history before treatment begins and remains your point of contact if unexpected symptoms arise.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Many people searching this question have either noticed itching themselves or read a forum post suggesting it is a widespread problem with Wegovy. The reality is more nuanced. The NHS semaglutide medicines page lists pruritus (the clinical word for itching) as an uncommon side effect, meaning it affects fewer than one in a hundred people. That puts it well below the headline reactions like nausea or diarrhoea, which affect a much larger share of users, particularly in the early weeks of treatment.
Skin itching with Wegovy typically falls into one of three categories: localised itching at or near the injection site, a broader skin sensitivity that can develop during dose escalation, or (rarely but importantly) the early sign of an allergic response. These three things feel similar to the person experiencing them but point in very different clinical directions. Treating them as equivalent, or assuming that any itch is just "something Wegovy does", is the misconception worth correcting first.
If you are looking at the broader question of how Wegovy and itchy skin relate over time, the pattern across clinical trial data and post-marketing reports is that localised injection-site reactions are most likely to appear early in treatment, often settling as the body adjusts.
The pre-filled Wegovy pen delivers semaglutide into the fatty tissue just beneath the skin, most commonly in the abdomen, thigh or upper arm. Any subcutaneous injection can provoke a localised response: redness, mild swelling, a raised bump, or itching at the puncture point. This is not a sign that something is seriously wrong; it is the skin's normal inflammatory response to a foreign object and a small volume of fluid.
A few practical factors make this more or less likely. Injecting into the same spot repeatedly concentrates localised reactions, rotating between different sites on the same body area, and between body areas across weeks, gives tissue time to recover. Injecting a pen that has just come out of the fridge introduces cold fluid into the skin, which can irritate nerve endings; allowing the pen to sit at room temperature for a short while before use (check the Patient Information Leaflet for the exact window) reduces this. Some people also find that the sensation is brief and disappears within an hour or two of each injection, particularly as they move through the titration schedule.
If you want more detail on whether Wegovy can cause skin pain or sensitivity beyond itching, that covers the broader injection-site picture.
A small number of people do experience a generalised allergic reaction to semaglutide, and if you are wondering specifically whether Wegovy makes you itch in a way that goes beyond a typical injection-site response, understanding the difference matters. The signs to watch for are itching that spreads well beyond the injection site, hives (raised, blotchy welts across the skin), swelling of the face, lips, tongue or throat, and any difficulty breathing or swallowing. These symptoms together constitute a potential serious allergic reaction and require urgent medical attention, call 999 or go to an A&E department rather than waiting to contact your prescriber.
The MHRA Yellow Card scheme allows patients to report suspected side effects from medicines directly to the UK's medicines regulator. If you experience an unexpected skin reaction while on Wegovy, reporting it via Yellow Card contributes to the ongoing safety monitoring of the medicine, it takes about five minutes and does not require a diagnosis, just a description of what you noticed and when.
Separately, if you are taking other medicines alongside semaglutide, some drugs are themselves associated with skin reactions, and it is worth a conversation with your prescriber about whether a new or changed medication could be the actual cause. Wegovy slows gastric emptying, which affects how quickly other oral medicines are absorbed, something worth raising if you started a new tablet around the same time the itching began.
Some people on Wegovy also notice that their skin feels drier or more sensitive than usual, which can tip over into mild itching even without a visible rash. Rapid weight loss (which semaglutide can produce) changes the mechanical stress on skin tissue, and reduced calorie intake can sometimes mean lower intake of the fats and micronutrients skin relies on. Staying well hydrated and keeping protein intake adequate are sensible practical steps while on treatment; your prescriber can advise on what is appropriate for your situation.
There is a separate question about whether Wegovy dries out your skin more directly, which is worth reading if the dryness element is more prominent for you than the itch itself. For context on how Wegovy works and the full side-effect profile, the Wegovy treatment overview brings all of that together.
One practical note: if your symptoms flared shortly after a dose increase (perhaps the step up to 1.7mg or 2.4mg) that timing matters. Skin reactions, like GI symptoms, can intensify temporarily at each new dose before settling. Knowing this in advance helps distinguish an expected adjustment response from something that warrants contacting your prescriber. If you are considering starting treatment and want to understand what Wegovy costs privately in the UK, that context is worth having before you begin. When you are ready to discuss whether semaglutide is right for you, speak to our prescribers through a free consultation, a real clinician reads your answers the same day, not software.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.